Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tourism Malaysia and MHTC Bring Malaysia Fair 2025 to Surabaya A Celebration of Culture, Cuisine, Travel, and Healthcare Excellence 2025-09-26 09:45
ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT 2025-09-25 02:40
The Hidden Genetic Threat Putting 1 in 5 at Cardiovascular Disease Risk: Global Experts Call for Action on Elevated Lipoprotein(a) 2025-09-24 20:21
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811) 2025-09-24 19:45
Xinhua Silk Road: Guotai Haitong Securities hosts conference on biopharma and AI in E. China's Shanghai 2025-09-24 09:02
TraceLink Delivers Intelligent Productivity Gains with OPUS Platform Expansion 2025-09-24 00:12
LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support Services 2025-09-23 21:15
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy 2025-09-23 20:01
Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress 2025-09-23 17:03
Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC 2025-09-23 10:22
IMRA Surgical Announces Collaboration with Telix Pharmaceuticals to Advance Radio-Guided Surgery Education and Training 2025-09-23 05:19
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer 2025-09-22 20:00
Hon'ble CM of Delhi, Smt. Rekha Gupta, Inaugurates Apollo Athenaa - Asia's First Dedicated Cancer Centre for Women 2025-09-22 15:43
First-in-Class Potential! FDA Clears IND Application for LBL-047, an Anti-BDCA2/TACI Bispecific Fusion Protein Developed by Leads Biolabs 2025-09-22 12:29
Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025 2025-09-19 20:00
European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively 2025-09-19 19:59
LabConnect Appoints Bill Finger as Senior Vice President, Global Strategic Services 2025-09-19 01:25
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease 2025-09-17 20:44
Malaysia Healthcare Week Debuts in Kuwait, Strengthening Malaysia-Kuwait Medical Partnership 2025-09-17 10:01
ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Migraine 2025-09-16 19:00